BofA Securities Resumes Bristol-Myers Squibb Co. (BMY) at Neutral

December 10, 2024 6:47 AM EST Send to a Friend
BofA Securities analyst Tim Anderson resumes coverage on Bristol-Myers Squibb Co. (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login